Skip to main content
logo
McKesson Corporation (LON:0JZU)
London flag London · Delayed Price · Currency is GBP · Price in USD
847.62
-1.32 (-0.16%)
At close: Nov 7, 2025

Revenue

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 20222016 - 2021
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 2016 - 2021
Prescription Technology Solutions Revenue
5.52B5.22B
Log In
Log In
Log In
Upgrade
Medical Surgical Solutions Revenue
11.45B11.39B
Log In
Log In
Log In
Upgrade
US Pharmaceutical Revenue
-327.72B
Log In
Log In
Log In
Upgrade
International Revenue
-14.72B
Log In
Log In
Log In
Upgrade
Revenue (Other)
370.12B11.00M
Log In
Log In
Log In
Upgrade
Revenue (Total)
387.09B359.05B
Log In
Log In
Log In
Upgrade

EBIT

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 20222016 - 2021
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 2016 - 2021
Prescription Technology Solutions Operating Profit
964.00M875.00M
Log In
Log In
Log In
Upgrade
Medical Surgical Solutions Operating Profit
937.00M773.00M
Log In
Log In
Log In
Upgrade
US Pharmaceutical Operating Profit
-4.00B
Log In
Log In
Log In
Upgrade
International Operating Profit
--213.00M
Log In
Log In
Log In
Upgrade
Operating Income (Other)
3.36B-1.02B
Log In
Log In
Log In
Upgrade
Operating Income (Total)
5.26B4.42B
Log In
Log In
Log In
Upgrade

Capital Expenditures

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 20222016 - 2021
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 2016 - 2021
US Pharmaceutical Capital Expenditures
-241.00M
Log In
Log In
Log In
Upgrade
Prescription Technology Solutions Capital Expenditures
-11.00M
Log In
Log In
Log In
Upgrade
Medical Surgical Solutions Capital Expenditures
-163.00M
Log In
Log In
Log In
Upgrade
International Capital Expenditures
-107.00M
Log In
Log In
Log In
Upgrade
Updated Sep 30, 2025. Data Source: Fiscal.ai.